VintaBio is a viral vector manufacturing technology company delivering its proprietary innovations through end-to-end CMO services. At the core of its offering is VintaProcess™, an intensified adherent manufacturing platform that simplifies AAV and lentiviral vector production by enriching full capsids at harvest, reducing downstream complexity, and enabling scalability from early development to commercial. Founded by gene therapy pioneers, VintaBio is accelerating gene therapy to patients.